Patient with histologically or cytologically proven locally advanced and/or metastatic adenocarcinoma of the pancreas;
Patient undergoing or failing medical treatment and comfort care only;
Patient with EVA ≥ 4 and/or requiring analgesics level 3;
Performans Status (ECOG) \< 3 ;
Informing the patient and obtaining free, informed and written consent signed by the patient and the investigator;
Patient affiliated or beneficiary of the social security system
You may not be if
Patient does not have a smartphone, tablet or computer;
Patient with no personal internet access at home (WIFI, wired), or via his smartphone;
Patient does not feel able to fill out an electronic questionnaire;
Patient cannot read or write French;
Patient does not speak and understand French;
Persons deprived of liberty or under guardianship or trusteeship ;
Dementia, mental alteration or psychiatric pathology that could compromise the patient's informed consent and/or compliance with the protocol and follow-up of the trial ;
Inability to submit to trial protocol follow-up for geographical, social, or other reasons ;
Patient participating in another interventional study evaluating treatment and pain management.
Clareo Health | Telemedicine in the Management of Pain in Patients With Advanced or Metastatic Pancreatic Cancer
